RECRUITING

A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To assess the effectiveness of Amisulpride to treat Post Operative Nausea and Vomiting (PONV) and to assess the effectiveness of Amisulpride to prevent PONV following bariatric surgery.

Official Title

A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea and Vomiting in the Bariatric Surgery Population

Quick Facts

Study Start:2024-09-13
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06585540

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * The study will recruit adult patients (Age 18-65) scheduled for bariatric surgery. Additional inclusion criteria include ASA class I-III and patients who plan to be inpatient for at least 24 hours.
  1. * Pregnant or breastfeeding
  2. * Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  3. * Congenital QTc abnormalities
  4. * Current use of droperidol
  5. * Parkinson's disease
  6. * Allergy to Barhemsys
  7. * GFR \< 30 mL/min/1.73m2
  8. * Emergency surgery or add-on cases

Contacts and Locations

Study Contact

Justin S Liberman, Medical Doctor
CONTACT
206-341-1298
justin.liberman@vmfh.org
David B Auyong, Medical Doctor
CONTACT
206-341-1298
David.Auyong@vmfh.org

Principal Investigator

Justin S Liberman, Medical Doctor
PRINCIPAL_INVESTIGATOR
Virginia Mason Medical Center

Study Locations (Sites)

Virginia Mason Medical Center
Seattle, Washington, 98101
United States

Collaborators and Investigators

Sponsor: Benaroya Research Institute

  • Justin S Liberman, Medical Doctor, PRINCIPAL_INVESTIGATOR, Virginia Mason Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-13
Study Completion Date2026-01

Study Record Updates

Study Start Date2024-09-13
Study Completion Date2026-01

Terms related to this study

Keywords Provided by Researchers

  • Post Operative Nausea and Vomiting
  • Bariatric Surgery
  • Bariatric
  • Barhemsys
  • Amisulpride

Additional Relevant MeSH Terms

  • Post Operative Nausea and Vomiting